Literature DB >> 30130432

Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy.

Petra Keul1, Amin Polzin2, Klaus Kaiser1, Markus Gräler3,4, Lisa Dannenberg2, Günter Daum5, Gerd Heusch1, Bodo Levkau1.   

Abstract

Dysfunctional HDL is associated with coronary artery disease (CAD), but its effect on inflammation in vascular smooth muscle cells (VSMCs) in atherosclerosis is unknown. We investigated the effect of healthy human HDL and CAD-HDL on TNF-α-driven inflammation in VSMCs and examined whether HDL-associated sphingosine-1-phosphate (HDL-S1P) could modulate inflammation with the aim of designing novel HDL-based anti-inflammatory strategies. Healthy human HDL, human CAD-HDL, and mouse HDL were isolated by ultracentrifugation, S1P was measured by liquid chromatography-tandem mass spectrometry, and TNF-α-induced inflammation was characterized by gene expression and analysis of NF-κB-dependent signaling. Mechanisms of S1P interference with TNF-α were assessed by S1P receptor antagonists, mouse knockouts, and short interfering RNA. We observed that healthy HDL potently inhibited the induction of TNF-α-stimulated inflammatory genes, such as iNOS (inducible NO synthase) and MMP9 (matrix metalloproteinase 9), a process that was entirely dependent on HDL-S1P, as evidenced by loss-of-function using S1P-less HDL and mimicked by genuine S1P. Inhibition was based on suppression of TNF-α-activated Akt signaling resulting in reduced IkBαSer32 and p65Ser534 NF-κB phosphorylation based on a persistent phosphatase and tensin homolog activation by S1P through the S1P receptor 2. Intriguingly, S1P suppressed inflammation even hours after initial TNF-α stimulation. The anti-inflammatory effect of healthy HDL correlated with HDL-S1P content and was superior to that of CAD-HDL featuring lower HDL-S1P. Nevertheless, therapeutic loading of HDL with S1P completely restored the anti-inflammatory capacity of CAD-HDL and greatly boosted that of both healthy and CAD-HDL. Suppression of inflammation by HDL-S1P defines a novel pathophysiologic characteristic that distinguishes functional from dysfunctional HDL. The anti-inflammatory HDL function can be boosted by S1P-loading and exploited by S1P receptor-targeting to prevent and even turn off ongoing inflammation.-Keul, P., Polzin, A., Kaiser, K., Gräler, M., Dannenberg, L., Daum, G., Heusch, G., Levkau, B. Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy.

Entities:  

Keywords:  CAD; S1P; TNF-α; VSMC; inflammation

Mesh:

Substances:

Year:  2018        PMID: 30130432     DOI: 10.1096/fj.201801245R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  18 in total

Review 1.  Hyperlipidaemia and cardioprotection: Animal models for translational studies.

Authors:  Ioanna Andreadou; Rainer Schulz; Lina Badimon; Adriana Adameová; Petra Kleinbongard; Sandrine Lecour; Panagiota-Efstathia Nikolaou; Ines Falcão-Pires; Gemma Vilahur; Nicholas Woudberg; Gerd Heusch; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2020-01-17       Impact factor: 8.739

Review 2.  Sphingosine 1-phosphate and inflammation.

Authors:  Hideru Obinata; Timothy Hla
Journal:  Int Immunol       Date:  2019-08-23       Impact factor: 4.823

3.  Regulation of ABCA1-mediated cholesterol efflux by sphingosine-1-phosphate signaling in macrophages.

Authors:  Mithila Vaidya; Julian A Jentsch; Susann Peters; Petra Keul; Sarah Weske; Markus H Gräler; Emil Mladenov; George Iliakis; Gerd Heusch; Bodo Levkau
Journal:  J Lipid Res       Date:  2019-01-17       Impact factor: 5.922

Review 4.  Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.

Authors:  Victoria A Blaho
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 5.  Sphingosine 1-phosphate and its regulatory role in vascular endothelial cells.

Authors:  Yan Qiu; Junyi Shen; Wenli Jiang; Yi Yang; Xiaoheng Liu; Ye Zeng
Journal:  Histol Histopathol       Date:  2022-02-04       Impact factor: 2.303

6.  lncRNA-SNHG14 Promotes Atherosclerosis by Regulating RORα Expression through Sponge miR-19a-3p.

Authors:  Baoliang Zhu; Jing Liu; Ying Zhao; Jing Yan
Journal:  Comput Math Methods Med       Date:  2020-08-25       Impact factor: 2.238

Review 7.  Efferocytosis of vascular cells in cardiovascular disease.

Authors:  Jody Tori O Cabrera; Ayako Makino
Journal:  Pharmacol Ther       Date:  2021-06-23       Impact factor: 12.310

8.  Serum levels of small HDL particles are negatively correlated with death or lung transplantation in an observational study of idiopathic pulmonary fibrosis.

Authors:  Amisha V Barochia; Maryann Kaler; Nargues Weir; Elizabeth M Gordon; Debbie M Figueroa; Xianglan Yao; Merte Lemma WoldeHanna; Maureen Sampson; Alan T Remaley; Geraldine Grant; Scott D Barnett; Steven D Nathan; Stewart J Levine
Journal:  Eur Respir J       Date:  2021-12-02       Impact factor: 33.795

Review 9.  Sphingosine 1-Phosphate in Malaria Pathogenesis and Its Implication in Therapeutic Opportunities.

Authors:  Gunanidhi Dhangadamajhi; Shailja Singh
Journal:  Front Cell Infect Microbiol       Date:  2020-08-14       Impact factor: 5.293

Review 10.  Sphingosine-1-Phosphate and Macrophage Biology-How the Sphinx Tames the Big Eater.

Authors:  Andreas Weigert; Catherine Olesch; Bernhard Brüne
Journal:  Front Immunol       Date:  2019-07-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.